Experimental modeling of hypoxia in pregnancy and early postnatal life

Interdisciplinary Toxicology

Volumn 2, Issue 1, 2009, Pages 28-32

  Mach, Mojmir ^a   Dubovický, Michal ^a   Navarová, Jana ^a   Brucknerová, Ingrid ^b   Ujházy, Eduard ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

animal models; antioxidants; behavior; hypoxia; pregnancy

Indexed keywords

EID: 84997311915     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-009-0005-3     Document Type: Article

References (44)

1. Azarbayjani F and Danielsson BR. (1998). Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs? Teratology 3: 117-126.
2. Barker SD. (1998). In utero programming of chronic disease. Clin Sci (Lond) 95: 115-128.
3. Bezek Š, Ujházy E, Mach M, Navarová J, Dubovický M. (2008). Developmental origin of chronic diseases: chronic implication. Interdisc Toxicol 1(1): 29-31. Bhat M, Grizenko N, Ben-Amor L, Joober R. (2005). Obstetric complications in children with attention deficit/hyperactivity disorder and learning disability. McGill Journal of Medicine 8(2): 109-113.
4. Brucknerová I, Ujházy E, Dubovický M, Mach M. (2008). Early assessment of the severity of asphyxia in term newborns using parameters of blood count. Interdisc Toxicol 1(3-4): 211-213.
5. Carter BS, Havercamp AD, Merenstein GB. (1993). The definition of acute perinatal asphyxia. Clin Perinatol 20: 287-303.
6. Danielson MK, Danielsson BR, Marchner H, Lundin M, Rundqvist E, Reiland S. (1992). Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity. Teratology 5: 485-497.
7. Danielsson BR, Azarbayjani F, Skold AC, Webster WS. (1997). Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 4: 271-281.
8. Dell'Anna E, Calzolari S, Molinari M, Iuvone L, Calimici R. (1991). Neonatal anoxia induced transitori hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav Brain Res 45: 125-134.
9. do Carmo Pinho Franco M, Nigro D, Fortes ZB, Tostes RC, Carvalho MH, Lucas SR, Gomes GN, Coimbra TM, Gil FZ. (2003). Intrauterine undernutrition-renal and vascular origin of hypertension. Cardiovasc Res. 60(2): 228-234.
10. Dobbing J, Sands J. (1979). Comparative aspects of the brain growth spurt. Early Hum Dev 3: 79-83.
11. Dubovický M, Mach M, Ujházy E, Juránek I, Navarová J, Kovacovský P, Rychlík I, Sadlonová I. (2000). Effect of neonatal anoxia on neurobehavioral development of rats. Biologia 55(Suppl. 8): 27-32.
12. Dubovický M, Kovacovský P, Ujházy E, Navarová J, Brucknerová I, Mach M. (2008). Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development. Interdisc Toxicol 1(3-4): 206-210.
13. Fantel AG, Person RE. (2002). Involvement of mitochondria and other free radical sources in normal and abnormal fetal development. Ann NY Acad Sci 959: 424-433.
14. Golan H, Kashtutsky I, Hallak M, Sorokin Y, Huleihel M. (2004). Maternal hypoxia during pregnancy delays the development of motor refl exes in newborn mice. Dev Neurosci 26(1): 24-29.
15. Hill A. (1991). Current concepts of hypoxic-ischemic cerebral injury in the term newborn. Pediatr Neurol 7: 317-325.
16. Hoeger H, Engidawork E, Stolzlechner D, Bubna-Littitz H, Lubec B. (2006). Long-term effect of moderate and profound hypothermia on morphology, neurological, cognitive and behavioural functions in a rat model of perinatal asphyxia. Amino Acids 31(4): 385-396.
17. Hogan MD, Hoel DG. (1989). Extrapolation to man. In. Principles and Methods in Toxicology Hayes, A.W., ed., Raven Press, New York, pp. 879-891.
18. Howe AM, Lipson AH, Sheffield LJ, Haan EA, Halliday JL, Jenson F, David DJ, Webster WS. (1995). Prenatal exposure to phenytoin, facial development, and a possible role for vitamin K. Am J Med Genet 58: 238-244.
19. Lubec B, Dell'Anna E, Fang-Kircher S, Marx M, Herrera-Marschnitz M, Lubec G. (1997). Decrease of brain protein kinase c, protein kinase a, cyclin-dependent kinase correlating with ph precedes neuronal death in neonatal asphyxia. J
20. Mach M, Dubovický M, Navarova J, Kovacovský P, Ujházy E. (2006). Vitamin E supplementation in phenytoin induced developmental toxicity in rats: postnatal study. Neuro Endocrinol Lett 27 Suppl 2: 69-73.
21. Mach M, Ujházy E, Dubovický M, Kovacovský P, Navarová J. (2005). High-dose vitamin E supplementation in phenytoin induced intrauterine hypoxia: teratological study. Biologia 60 Suppl. 17: 45-49.
22. Mach M, Ujházy E, Dubovický M, Navarová J, Blažíček P, Šoltés L. (2001). Structural and functional changes in rat offspring induced by prenatal phenytoin administration. Med Mil Lett LXX Suppl 2: 79-82.
23. Makatsori A, Dubovický M, Ujházy E, Bakoš J, Ježová D. (2005). Neuroendocrine changes in adult female rats prenatally exposed to phenytoin. Neurotoxicol Teratol 27: 509-514.
24. Martz F, Failinger C III., Blake DA. (1977). Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharmacol Exp Ther 203: 231-239.
25. McDonald JW, Silverstein FS, Johnston MV. (1988). Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459: 200-203.
26. Miller JA. (1971). New approaches to preventing brain damage during asphyxia. Am J Obstet Gynecol 110(8): 1125-1133.
27. Monaghan DT, Bridges RJ, Cotman CW. (1989). The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365-402.
28. Monie IW, Armstrong RM, Nelson MM. (1961). Hydrocephalus and other abnormalities in rat young resulting from maternal pteroylglutamic acid deficiency from the 8th to 10th days of pregnancy. Teratology 1: 8.
29. Nyakas C, Buwalda B, Luiten PGM. (1996). Hypoxia and brain development. Prog Neurobiol 49: 1-51.
30. Olney JW. (1989). Excitotoxicity and N-methyl-D-aspartate receptors. Drug Dev Res 17: 299-319.
31. Pulera MR, Adams LM, Liu H, Santos DG, Nishimura RN, Yang F, Cole GM, Wasterlain CG. (1998). Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 29: 2622-2630.
32. Sheldon RA, Chuai J, Ferriero DM. (1996). A rat model for hypoxic-ischemic brain damage in very premature infants. Biol Neonate 69: 327-341.
33. Spandou E, Karkavelas G, Soubasi V, Avgovstides-Savvopoulou P, Loizidis T, Guiba-Tziampiri O. (1999). Effect of ketamine on hypoxic-ischemic brain damage in newborn rats. Brain Res 819: 1-7.
34. Tuor UI, Del Bigio MR, Chumas PD. (1996). Brain damage due to cerebral hypoxia/ ischemia in the neonate: pathology and pharmacological modification. Cerebrovascular & Brain Metabolism Review 8: 159-193.
35. Uehara H, Yoshioka H, Kawase S, Nagai H, Ohmae T, Hasegawa K, Sawada T. (1999). A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion. Brain Res 837: 213-220.
36. Ujházy E, Dubovický M, Mach M, Juránek I, Navarová J, Sadlonová I, Gajdošík A. (2000). Effect of phenytoin on prenatal and postnatal development of rats. Biologia 55: 125-130.
37. Ujházy E, Mach M, Dubovický M, Navarova J, Šoltés L, Juránek I, Brucknerová I, Zeman M. (2004). Effect of melatonin and stobadine on maternal and embryofoetal toxicity in rats due to intrauterine hypoxia induced by phenytoin administration. Cent Eur J Public Health 12 Suppl: S83-S86.
38. Ujházy E, Schmidtová M, Dubovický M, Navarová J, Brucknerová I, Mach M. (2006). Neurobehavioural changes in rats after neonatal anoxia: effect of antioxidant stobadine pretreatment. Neuro Endocrinol Lett 27 Suppl 2: 82-85.
39. Volpe JJ. (1995). Hypoxic-ischemic encephalopathy; in Neurology of the Newborn, Volpe, J. J., ed., Philadelphia, Saunders, pp. 211-369.
40. Volpe JJ. (1987). Neurology of the newborn. In: Hypoxic-ischemic encephalopathy: biochemical and physiological aspects. Volpe JJ, ed., WB Saunders, Philadelphia, p.22.
41. Wells PG. Vo HPN. (1989). Effects of the tumor promoter 12-0-tetradecanolylphorbol-13-acetate on phenytoin-induced embryopathy in mice. Toxicol Appl Pharmacol 97: 398-405.
42. Wells PG, Winn LM. (1996). Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 1: 1-40.
43. Windle WF, Becker RF. (1942). Effect of anoxia at birth on the central nervous system of the guinea pig. Proc Soc Exp Biol Med 51: 213-219.
44. Invest Med 45: 284-294.